VBI Vaccines Inc. (Nasdaq: VBIV) (“VBI”) is scheduled to present at the Bloom Burton Healthcare Investor Conference on Monday, May 2nd at 1:30 PM ET. The event is being held at the Sheraton Centre Toronto Hotel in Toronto, Canada.

During the presentation, Jeff Baxter, VBI’s President and CEO, will provide an overview of VBI and its platform technologies, and will summarize recent developments in the company’s pipeline of vaccine candidates. Mr. Baxter will also discuss VBI’s planned merger with SciVac Therapeutics Inc. (TSX:VAC and OTCQX: SVACF) (“SciVac”). SciVac’s flagship product is Sci-B-Vac®, a commercial hepatitis B vaccine.Now in its fourth year, the Bloom Burton Healthcare Investor Conference attracts publicly traded and venture-backed private companies as well as promising pre-venture companies in the healthcare industry. For additional information, or to schedule a one-on-one meeting with VBI management, please contact ir@vbivaccines.com.

Event Details

 

SUBSCRIBE TO RECEIVE IMPORTANT NEWS AND INSIGHTS BY EMAIL